169 related articles for article (PubMed ID: 10404811)
1. The effect of estradiol and a combined estradiol/progestagen preparation on insulin sensitivity in healthy postmenopausal women.
Duncan AC; Lyall H; Roberts RN; Petrie JR; Perera MJ; Monaghan S; Hart DM; Connell JM; Lumsden MA
J Clin Endocrinol Metab; 1999 Jul; 84(7):2402-7. PubMed ID: 10404811
[TBL] [Abstract][Full Text] [Related]
2. The effects of sequential combined oral 17beta-estradiol norethisterone acetate on insulin sensitivity and body composition in healthy postmenopausal women: a randomized single blind placebo-controlled study.
Walker RJ; Lewis-Barned NJ; Sutherland WH; Goulding A; Edwards EA; de Jong SA; Gold E; Walker HL
Menopause; 2001; 8(1):27-32. PubMed ID: 11201511
[TBL] [Abstract][Full Text] [Related]
3. The effects of transdermal estradiol in combination with oral norethisterone on lipoproteins, coagulation, and endothelial markers in postmenopausal women with type 2 diabetes: a randomized, placebo-controlled study.
Perera M; Sattar N; Petrie JR; Hillier C; Small M; Connell JM; Lowe GD; Lumsden MA
J Clin Endocrinol Metab; 2001 Mar; 86(3):1140-3. PubMed ID: 11238498
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women.
O'Sullivan AJ; Ho KK
J Clin Endocrinol Metab; 1995 Jun; 80(6):1783-8. PubMed ID: 7775623
[TBL] [Abstract][Full Text] [Related]
5. Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17beta-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study.
Castelo-Branco C; Palacios S; Vázquez F; Villero J; Ferrer J; Ascaso C; Balasch J
Fertil Steril; 2007 Aug; 88(2):383-9. PubMed ID: 17561009
[TBL] [Abstract][Full Text] [Related]
6. Lipids and clotting factors during low dose transdermal estradiol/norethisterone use.
Brynhildsen J; Hammar M
Maturitas; 2005 Apr; 50(4):344-52. PubMed ID: 15780536
[TBL] [Abstract][Full Text] [Related]
7. Optimal tolerability of ultra-low-dose continuous combined 17beta-estradiol and norethisterone acetate: laboratory and safety results.
Samsioe G; Hruska J;
Climacteric; 2010 Feb; 13(1):34-44. PubMed ID: 20001563
[TBL] [Abstract][Full Text] [Related]
8. Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study.
Davis SR; Stuckey BG; Norman RJ; Papalia MA; Drillich A; Bell RJ
Menopause; 2008; 15(6):1065-9. PubMed ID: 18806686
[TBL] [Abstract][Full Text] [Related]
9. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
[TBL] [Abstract][Full Text] [Related]
10. Monofluorophosphate combined with hormone replacement therapy induces a synergistic effect on bone mass by dissociating bone formation and resorption in postmenopausal women: a randomized study.
Alexandersen P; Riis BJ; Christiansen C
J Clin Endocrinol Metab; 1999 Sep; 84(9):3013-20. PubMed ID: 10487657
[TBL] [Abstract][Full Text] [Related]
11. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
Rozenberg S; Ylikorkala O; Arrenbrecht S
Int J Fertil Womens Med; 1997; 42 Suppl 2():376-87. PubMed ID: 9397385
[TBL] [Abstract][Full Text] [Related]
12. Effects of oral and transdermal oestrogen replacement therapy on plasma levels of insulin-like growth factors and IGF binding proteins 1 and 3: a cross-over study.
Helle SI; Omsjø IH; Hughes SC; Botta L; Hüls G; Holly JM; Lønning PE
Clin Endocrinol (Oxf); 1996 Dec; 45(6):727-32. PubMed ID: 9039339
[TBL] [Abstract][Full Text] [Related]
13. Differential effect of transdermal estrogen plus progestagen replacement therapy on insulin metabolism in postmenopausal women: relation to their insulinemic secretion.
Cucinelli F; Paparella P; Soranna L; Barini A; Cinque B; Mancuso S; Lanzone A
Eur J Endocrinol; 1999 Mar; 140(3):215-23. PubMed ID: 10216516
[TBL] [Abstract][Full Text] [Related]
14. Effects of oral and transdermal 17beta-estradiol with cyclical oral norethindrone acetate on insulin sensitivity, secretion, and elimination in postmenopausal women.
Spencer CP; Godsland IF; Cooper AJ; Ross D; Whitehead MI; Stevenson JC
Metabolism; 2000 Jun; 49(6):742-7. PubMed ID: 10877199
[TBL] [Abstract][Full Text] [Related]
15. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
Araújo DA; Farias ML; Andrade AT
Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
[TBL] [Abstract][Full Text] [Related]
16. Endometrium protection and acceptability of nasally administered continuously combined hormone therapy: a multicentre, multinational, double-blind trial in post-menopausal women evaluating three regimens of 17beta-estradiol and norethisterone when compared with an orally administered 17beta-estradiol norethisterone regimen.
Rozenberg S; Pornel B; Koninckx PR; Palacios S; Christiansen C
Hum Reprod; 2009 Jul; 24(7):1739-47. PubMed ID: 19351658
[TBL] [Abstract][Full Text] [Related]
17. Transdermal estradiol/norethisterone. A review of its pharmacological properties and clinical use in postmenopausal women.
Wiseman LR; McTavish D
Drugs Aging; 1994 Mar; 4(3):238-56. PubMed ID: 8199397
[TBL] [Abstract][Full Text] [Related]
18. Hormonal and metabolic effects of transdermal estradiol/progestagen administration in postmenopausal women.
Perrone G; Falaschi P; Capri O; Pastore R; Galoppi P; D'Urso R; Martocchia A; Anelli G; Zichella L
Int J Fertil Menopausal Stud; 1994; 39(4):202-7. PubMed ID: 7951402
[TBL] [Abstract][Full Text] [Related]
19. Low-dose hormone therapy and carbohydrate metabolism.
Li C; Samsioe G; Borgfeldt C; Bendahl PO; Wilawan K; Aberg A
Fertil Steril; 2003 Mar; 79(3):550-5. PubMed ID: 12620438
[TBL] [Abstract][Full Text] [Related]
20. Effects of oral continuous 17beta-estradiol plus norethisterone acetate replacement therapy on abdominal subcutaneous fat, serum leptin levels and body composition.
Yüksel H; Odabaşi AR; Demircan S; Karul A; Kozaci LD; Köseoğlu K; Kizilkaya K; Başak O
Gynecol Endocrinol; 2006 Jul; 22(7):381-7. PubMed ID: 16864148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
